B-42 Trial: MammaPrint Utility for Prediction of Extended Letrozole Therapy, ASCO 2021 NSABP B-42 Trial, ASCO 2021 Abstract #502 Authors: Rastogi, et al.Read More Karen Guzdzial2024-03-26T06:56:17-07:00June 7th, 2021|Evidence, Extended Endocrine, NSABP B-42| Read More